Patient flow management solutions market is valued at USD 2.04 billion in 2025 and is poised to reach USD 13.88 billion by 2035, representing a CAGR of 21.1% during the forecast period. Currently, the real-time locating system segment dominates the market, accounting for 55% of the overall revenue share. Among the components, currently software accounts for the highest share (65%) of the market and this segment is likely to remain dominant during the forecast period. In April 2024, ABOUT Healthc...

The global orphan drug market size is expected to grow from USD 236.27 billion in 2025 to reach USD 667.48 billion by 2035, representing a CAGR of 10.94% over the forecast period. With rising risk of rare diseases and some rare oncological disorders, the demand for orphan drugs has significantly increased to treat patients. A recent report published by National Center for Advancing Translational Sciences highlighted that nearly 10,000 rare diseases affect the US population. Moreover, according t...

The global in vitro diagnostics market, valued at USD 113 billion in 2025, is projected to reach USD 118 billion in 2026 and USD 190 billion by 2035, with a 5.4% CAGR during the forecast period 2026 to 2035. The laboratory segment holds the highest share (~85%) of the market. With regards to type of offering, the reagents segment dominates the global market with 75% of the market share. Based on the type of technology, the immunoassay segment holds the largest market share (nearly 35%) in 202...

The global smart insulin pens market is valued at USD 4.31 billion in 2024 and is poised to reach USD 10.36 billion by 2035, representing a CAGR of 8.30% during the forecast period. On the basis of geographical regions, the global smart insulin pens market value is distributed across North America, Europe, Asia Pacific, Middle East and North Africa, and Latin America. According to our market analysis, presently North America holds the highest share (35%) of the market, driven by the growing case...

The global DNA read, write and edit market is expected to increase from USD 8.33 billion in 2025 to USD 29.78 billion by 2035, representing a CAGR of 13.6% during the forecast period. Presently, the key players of the industry are focusing on the development of next generation genome sequencing technologies that aid in editing genes precisely with higher accuracy rate. For instance, in October 2024, Illumina launched the MiSeq

The manufacturing execution system market, valued at USD 4.62 billion in 2025, is projected to grow to USD 5.36 billion in 2026 and USD 20.46 billion by 2035, representing a CAGR of 16.0% during the forecast period. In recent years, with the mounting penetration of technological advancements, the market for manufacturing execution systems has been evolving exponentially. The trend of integrated quality management systems is one of the latest trends in the manufacturing execution system industry....

The global automated suturing devices market is estimated to grow from 3.40 billion in 2024 to USD 6.60 billion by 2035, at a CAGR of 6.20% during the forecast period, till 2035. The global market is propelled by various factors such as growing demand for minimally invasive treatment and rising risk of chronic conditions. A recent report of Centers for Disease Control and Prevention stated that, nearly 129 million people in United States are suffering from at least one chronic disease. Therefore...

The global amyotrophic lateral sclerosis market size is valued at USD 0.79 billion in 2024 and is estimated to reach USD 1.38 billion by 2035, representing a CAGR of 5.2% during the forecast period. It is important to highlight here that in May 2024, European Medicines Agency (EMA) approved Biogen

The Asia-Pacific women's digital health market is estimated to grow at a CAGR of 19.3% during the forecast period. The market is likely to cross USD 3,770 million by 2035. As per the recent report of the Asia-Pacific Resource and Research Center for Women, every year nearly 265,884 Asian women are diagnosed with cervical cancer, and around 42,735 deaths have been reported from the disease. Considering the necessity of maintaining female reproductive, fertility and general health, various FemTech...

The Europe women's digital health market is valued at USD 0.73 billion in 2024 and this value is anticipated to reach USD 4.8 billion by 2035. The market has been projected to grow at a compounded annual growth rate (CAGR) of 17.9% during the forecast period. The opportunity in Europe women

The global meditation market size is estimated to grow from USD 8.87 billion in 2025 to USD 37.53 billion by 2035, representing a CAGR of 15.52% during the forecast period. In November 2024, Headspace announced the collaboration with World of Hyatt, in order to offer five-episode video series for the latter

The multiomics market size is projected to grow from USD 3.10 billion in 2025 to USD 12.65 billion by 2035, representing a CAGR of 15.09% during the forecast period till 2035. Biomedical firms and emerging drug discovery companies are investing in the industry to leverage the technology. For instance, in May 2024, MultiOmic Health raised $6.2 million in a seed funding extension to develop its precision therapeutic platform for metabolic syndrome-related conditions. The funding was led by Hoxton...

The global radiopharmaceutical manufacturing market is estimated to grow from $3.7 billion in 2024 to $9.0 billion by 2035, representing a CAGR of 8.44% during the forecast period till 2035. It is worth highlighting that around 40 million diagnostic procedures are conducted, annually, which specifically utilize only one radioisotope, Technitium-99m. Typically, diagnostic tests are performed by using highly specialized imaging solutions, such as single photon emission computed tomography (SPECT)...

The global biologics market size is worth around $411 billion in 2024 and is expected to reach $962 billion by 2035, representing a higher compounded annual growth rate (CAGR) of 8.04% during the forecast period. According to the World Health Organization report, nearly 422 million people across the globe are suffering from diabetes. Moreover, nearly 41 million people die annually due to non-communicable diseases, which is equivalent to around 74% of all deaths occurring across the globe. The ri...

The global monoclonal antibodies in veterinary health market is estimated to grow from USD 0.8 billion in 2024 to USD 4.3 billion by 2035, representing a higher CAGR of 17% during the forecast period. According to the report of the American Veterinary Medical Association, nearly 1 out of 4 dogs are estimated to have neoplasia (a form of cancer). The increasing incidence of cancer in companion animals, particularly in dogs, has underscored the requirement of advanced therapeutics to eradicate can...

The global cell and gene therapy CRO market, valued at USD 1.7 billion in 2024, is estimated to reach USD 1.9 billion in 2025 and USD 3.5 billion by 2035, representing a CAGR of 6.3% during the forecast period. Presently, over 90 cell and gene therapies have been approved globally. Notable examples of recently approved therapies include (in reverse chronological order of year of approval) Fucaso (2023; developed by IASO Bio) for the treatment of multiple myeloma, Elvediys, (2023; developed by Sa...

The global medical tourism market size is estimated to grow from USD 33.78 billion in 2024 to USD 176.17 billion by 2035, representing a CAGR of 16.20% during the forecast period. Medical tourism is a common practice of traveling to different destinations and across international borders for healthcare facilities. With rising disposable income, medical insurance coverages and growing preferences for advanced healthcare services, medical tourism is booming across the globe. According to the recen...

The influenza vaccine market size is projected to grow from USD 8.27 billion in 2025 to USD 17.41 billion by 2035, representing a CAGR of 7.72% during the forecast period till 2035. Influenza, also known as flu, an acute respiratory infection spread by the influenza virus is a common viral infectious disease. According to WHO

The medical second opinion market size is projected to grow from USD 7.42 billion in 2025 to USD 29.44 billion by 2035, representing a CAGR of 14.77% during the forecast period till 2035. The distribution of the market for second opinion is divided into health insurance companies, hospitals, physicians, specialty clinics, and others. As per this medical second opinion market report, the hospital segment is expected to drive the market demand with (~41%) of the market share and will likely domina...